CVM
Price
$2.49
Change
-$0.03 (-1.19%)
Updated
Jul 3 closing price
Capitalization
12.79M
EYPT
Price
$9.72
Change
+$0.06 (+0.62%)
Updated
Jul 3 closing price
Capitalization
668.85M
24 days until earnings call
Interact to see
Advertisement

CVM vs EYPT

Header iconCVM vs EYPT Comparison
Open Charts CVM vs EYPTBanner chart's image
Cel-Sci
Price$2.49
Change-$0.03 (-1.19%)
Volume$192.16K
Capitalization12.79M
EyePoint Pharmaceuticals
Price$9.72
Change+$0.06 (+0.62%)
Volume$332.55K
Capitalization668.85M
CVM vs EYPT Comparison Chart in %
Loading...
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVM vs. EYPT commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVM is a Hold and EYPT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CVM: $2.49 vs. EYPT: $9.72)
Brand notoriety: CVM: Notable vs. EYPT: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVM: 76% vs. EYPT: 41%
Market capitalization -- CVM: $12.79M vs. EYPT: $668.85M
CVM [@Biotechnology] is valued at $12.79M. EYPT’s [@Biotechnology] market capitalization is $668.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVM’s FA Score shows that 0 FA rating(s) are green whileEYPT’s FA Score has 1 green FA rating(s).

  • CVM’s FA Score: 0 green, 5 red.
  • EYPT’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than CVM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVM’s TA Score shows that 4 TA indicator(s) are bullish while EYPT’s TA Score has 4 bullish TA indicator(s).

  • CVM’s TA Score: 4 bullish, 3 bearish.
  • EYPT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CVM is a better buy in the short-term than EYPT.

Price Growth

CVM (@Biotechnology) experienced а +2.05% price change this week, while EYPT (@Biotechnology) price change was -6.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

EYPT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($669M) has a higher market cap than CVM($12.8M). EYPT YTD gains are higher at: 30.470 vs. CVM (-79.245). CVM has higher annual earnings (EBITDA): -21.96M vs. EYPT (-144.55M). EYPT has more cash in the bank: 318M vs. CVM (1.92M). CVM has less debt than EYPT: CVM (10.5M) vs EYPT (24.1M). EYPT has higher revenues than CVM: EYPT (56M) vs CVM (0).
CVMEYPTCVM / EYPT
Capitalization12.8M669M2%
EBITDA-21.96M-144.55M15%
Gain YTD-79.24530.470-260%
P/E RatioN/AN/A-
Revenue056M-
Total Cash1.92M318M1%
Total Debt10.5M24.1M44%
FUNDAMENTALS RATINGS
CVM vs EYPT: Fundamental Ratings
CVM
EYPT
OUTLOOK RATING
1..100
5074
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
10092
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
6637
P/E GROWTH RATING
1..100
5717
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EYPT's Valuation (61) in the Pharmaceuticals Major industry is somewhat better than the same rating for CVM (98) in the Biotechnology industry. This means that EYPT’s stock grew somewhat faster than CVM’s over the last 12 months.

EYPT's Profit vs Risk Rating (92) in the Pharmaceuticals Major industry is in the same range as CVM (100) in the Biotechnology industry. This means that EYPT’s stock grew similarly to CVM’s over the last 12 months.

EYPT's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as CVM (100) in the Biotechnology industry. This means that EYPT’s stock grew similarly to CVM’s over the last 12 months.

EYPT's Price Growth Rating (37) in the Pharmaceuticals Major industry is in the same range as CVM (66) in the Biotechnology industry. This means that EYPT’s stock grew similarly to CVM’s over the last 12 months.

EYPT's P/E Growth Rating (17) in the Pharmaceuticals Major industry is somewhat better than the same rating for CVM (57) in the Biotechnology industry. This means that EYPT’s stock grew somewhat faster than CVM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CVMEYPT
RSI
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
78%
Momentum
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TZOO13.310.09
+0.68%
Travelzoo
ASX10.370.07
+0.68%
ASE Technology Holding Co Ltd
NVRI8.810.04
+0.46%
Enviri Corp
SVV10.88N/A
N/A
Savers Value Village
SCNX1.45-0.01
-0.68%
Scienture Holdings Inc

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
+0.62%
OCUL - EYPT
64%
Loosely correlated
+1.69%
LYRA - EYPT
58%
Loosely correlated
-3.33%
RXRX - EYPT
55%
Loosely correlated
+1.15%
BEAM - EYPT
55%
Loosely correlated
+0.65%
CRSP - EYPT
54%
Loosely correlated
+0.97%
More